Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Gains from Sales and Divestitures (2019 - 2023)

INVO Fertility (IVF) has disclosed Gains from Sales and Divestitures for 5 consecutive years, with $16505.0 as the latest value for Q3 2023.

  • On a quarterly basis, Gains from Sales and Divestitures fell 87.91% to $16505.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $16505.0, a 87.91% decrease, with the full-year FY2022 number at $143174.0, down 30.17% from a year prior.
  • Gains from Sales and Divestitures was $16505.0 for Q3 2023 at INVO Fertility, roughly flat from $16505.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.2 million in Q1 2020 to a low of $2083.0 in Q4 2019.
  • A 5-year average of $147945.1 and a median of $71312.5 in 2020 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: surged 2973.5% in 2020, then plummeted 97.89% in 2021.
  • INVO Fertility's Gains from Sales and Divestitures stood at $2083.0 in 2019, then soared by 2973.5% to $64021.0 in 2020, then skyrocketed by 220.26% to $205031.0 in 2021, then tumbled by 30.17% to $143174.0 in 2022, then tumbled by 88.47% to $16505.0 in 2023.
  • Per Business Quant, the three most recent readings for IVF's Gains from Sales and Divestitures are $16505.0 (Q3 2023), $16505.0 (Q2 2023), and $179798.0 (Q1 2023).